Esenflox Eye Drop contains Levofloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic indicated for the treatment of bacterial infections of the eye. Levofloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, repair, and recombination, thereby exerting bactericidal activity against susceptible Gram-positive and Gram-negative pathogens. Esenflox Eye Drop is primarily prescribed for bacterial conjunctivitis, keratitis, and other superficial ocular infections caused by susceptible strains. The formulation ensures rapid penetration into ocular tissues, providing effective antimicrobial concentrations at the site of infection. It is typically administered as one or two drops into the affected eye(s) every 2 to 4 hours initially, followed by a reduced frequency as the infection improves, according to the prescribing physician’s instructions. Patients should avoid contaminating the dropper tip and adhere strictly to the prescribed dosage to prevent resistance development. Common adverse effects may include transient burning or stinging upon instillation, mild ocular irritation, or dryness. Esenflox Eye Drop is contraindicated in individuals with hypersensitivity to levofloxacin or other quinolones. Caution is advised in patients with a history of tendon disorders related to quinolone use. Proper medical evaluation is essential before initiating therapy.